KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Charles River Laboratories International (CRL) Long-Term Debt Issuances (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Long-Term Debt Issuances data on record, last reported at $156.7 million in Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances rose 49.5% year-over-year to $156.7 million; the TTM value through Dec 2025 reached $1.2 billion, up 13.49%, while the annual FY2025 figure was $1.2 billion, 13.49% up from the prior year.
  • Long-Term Debt Issuances reached $156.7 million in Q4 2025 per CRL's latest filing, up from $107.5 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $3.0 billion in Q2 2021 and bottomed at $51.2 million in Q3 2023.
  • Average Long-Term Debt Issuances over 5 years is $649.5 million, with a median of $428.3 million recorded in 2024.
  • Peak YoY movement for Long-Term Debt Issuances: skyrocketed 111972800.0% in 2021, then crashed 92.67% in 2023.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $831.4 million in 2021, then crashed by 81.51% to $153.8 million in 2022, then skyrocketed by 188.31% to $443.3 million in 2023, then plummeted by 76.36% to $104.8 million in 2024, then soared by 49.5% to $156.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were $156.7 million in Q4 2025, $107.5 million in Q3 2025, and $547.0 million in Q2 2025.